United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$420Mraised across 2 rounds since 2021, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
RA Capital Management
Wellington Management
Franklin Templeton
Janus Henderson Investors
Cormorant Asset ManagementSource recordedSEC filing: $120M sold, first sale Feb 2021
From the SEC filings it signed: 6 on the team.
On the board, as filediBong J. KohBrian J. DanielsLaura J. StoppelYong-Jun J. HuhYu-Kyeong J. HwangYvonne J. Yamanaka
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Artiva Biotherapeutics's investors include RA Capital Management, Franklin Templeton, Janus Henderson Investors, Cormorant Asset Management and Wellington Management.
Artiva Biotherapeutics has raised $420M across 2 rounds since 2021.
Artiva Biotherapeutics's most recent round was an Undisclosed round of $300M in May 2026.
Its most recent round, $300M in May 2026, is also its largest on record.
Artiva Biotherapeutics's first round on record, in Feb 2021, was backed by RA Capital Management, Wellington Management and Franklin Templeton and 2 others.
Artiva Biotherapeutics's latest named round is an Undisclosed round, in May 2026.
Artiva Biotherapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
